Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2023 Earnings Call Transcript February 2, 2023
Christopher O’Reilly: Thank you for taking time out of your very busy schedule to join us for the FY €˜22 Q3 Earnings Announcement by Takeda. My name is O’Reilly, Head of IR. I’ll be the master of ceremony today. Before starting, I’d like to remind everyone that we will be using forward-looking statements in the meaning of the Private Securities Litigation Reform Act of 1995. Actual results...
